As for Lilly ( LLY ), Bernstein said its outperform rating “hinges on what they can do with the cash they generate from ...
Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...
Analyst Mohit Bansal of Wells Fargo maintained a Hold rating on Amgen (AMGN – Research Report), retaining the price target of $335.00.
With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, ...
Bernstein said Thursday it has started research coverage of US biopharma stocks, voicing a positive outlook for the sector.
Amgen today announced the presentation of positive top-line results from the Phase 3 MINT trial evaluating the efficacy and safety of UPLIZNA® (inebilizumab-cdon) for the treatment of adults with ...
This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.
The firm has issued Outperform ratings for Eli Lilly and Company (NYSE:LLY), Gilead Sciences (NASDAQ:GILD), and Amgen (NASDAQ:AMGN). Analysts note that Gilead's rating is supported by the ...
Medpage Today on MSN6d
Distant Recurrence Risk in Early Breast Cancer on the DeclineThe long-term risk of distant recurrence for women with early breast cancer has declined significantly, a decades-long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback